Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd

sales@dingminpharma.com

86-311-67591193

Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
HomeProductsAPIs And IntermediatesAPIs PowderPowder Trametinib GSK-1120212 871700-17-3

Powder Trametinib GSK-1120212 871700-17-3

  • $5
    ≥1
    Bag/Bags
Payment Type:
L/C,T/T,Paypal
Incoterm:
FOB,CIF
Min. Order:
1 Bag/Bags
Transportation:
Ocean,Air
Port:
Shanghai
Share:
  • Product Description
Overview
Product Attributes

Model No.871700-17-3

BrandDM

Supply Ability & Additional Information

Packagingdouble PE with aluminium foil bag

Productivity100kg/month

TransportationOcean,Air

Place of OriginHebei,China

Supply Ability100kg/month

CertificateISO9001

PortShanghai

Payment TypeL/C,T/T,Paypal

IncotermFOB,CIF

Packaging & Delivery
Selling Units:
Bag/Bags
Package Type:
double PE with aluminium foil bag
Picture Example:

Identification
Name   GSK-1120212
Synonyms   N-[3-[3-Cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-3,4,6,7-tetrahydro-6,8-dimethyl-2,4,7-trioxopyrido[4,3-d]pyrimidin-1(2H)-yl]phenyl]acetamide
Molecular Structure  
 
Molecular Formula   C26H23FIN5O4
Molecular Weight   615.39
CAS Registry Number   871700-17-3

We are the professional manufacturer of API,Raw Material Pharma,Pharmaceutical Intermediates,Active Pharmaceutical Ingredients ,Agrochemical Intermediates and  Fine Chemicals.with best quality and competitive price.

Product Categories : APIs And Intermediates > APIs Powder

Email to this supplier
  • *Subject:
  • *To:
    Ms. Lily
  • *Email:
  • *Message:
    Your message must be between 20-8000 characters
HomeProductsAPIs And IntermediatesAPIs PowderPowder Trametinib GSK-1120212 871700-17-3
Send Inquiry
*
*

Related Products List

Home

Product

Phone

About Us

Inquiry

We will contact you immediately

Fill in more information so that we can get in touch with you faster

Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.

Send